Thrombotic Microangiopathy After Kidney Transplantation: Insights Into Genetic Etiology and Clinical Outcomes

Thrombotic Microangiopathy After Kidney Transplantation: Insights Into Genetic Etiology and Clinical Outcomes

Introduction: Thrombotic microangiopathy (TMA), characterized by small-vessel thrombosis caused by endothelial injury, presents significant diagnostic and treatment challenges in kidney transplantation. Methods: To investigate the factors associated with posttransplant TMA, we conducted a retrospect...

Full description

Saved in:

Bibliographic Details
Main Authors:	Massini Merzkani, Nyein Chann Wai Lynn, Karen Flores, Gaurav Rajashekar, Kristin Progar, Rowena Delos Santos, John P. Atkinson, Daniel C. Brennan, Anuja Java
Format:	Article
Language:	English
Published:	Elsevier 2025-04-01
Series:	Kidney International Reports
Subjects:	antibody-mediated rejection calcineurin inhibitors complement genetics kidney transplantation thrombotic microangiopathy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024925000518
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Thrombotic Microangiopathy in Pregnancy: Current Understanding and Management Strategies
by: Manuel Urra, et al.
Published: (2024-08-01)

Ten tips for managing complement-mediated thrombotic microangiopathies (formerly atypical hemolytic uremic syndrome): narrative review
by: Pilar Musalem
Published: (2025-03-01)

Thrombotic Microangiopathy as an Emerging Complication of Viral Vector–Based Gene Therapy
by: Nora Schwotzer, et al.
Published: (2024-07-01)

Thrombotic microangiopathy in IgA nephropathy: pathophysiology, histopathology, and treatment perspectives
by: Ali Rastegar-Kashkouli, et al.
Published: (2024-05-01)

THROMBOTIC MICROANGIOPATHY IN HAEMATOPOIETIC CELL TRANSPLANTATION:AN UPDATE
by: Hillard Michael Lazarus, et al.
Published: (2010-08-01)

The outcome of thrombotic microangiopathy in kidney transplant recipients
by: Kanza Haq, et al.
Published: (2024-11-01)

Effective Management of Carfilzomib-Induced Thrombotic Microangiopathy in Multiple Myeloma Using Eculizumab
by: Jennifer Kim, et al.
Published: (2025-06-01)

Lupus nephritis and thrombotic microangiopathy: A review
by: Larisa A. Bobrova, et al.
Published: (2024-01-01)

Rare Case of Congenital Thrombotic Thrombocytopenic Purpura Presenting as Posttransplant Thrombotic Microangiopathy
by: Akila Viswanathan, et al.
Published: (2024-12-01)

Clinicopathological Spectrum and Treatment Outcome of Thrombotic Microangiopathy
by: Sarang Vijayan, et al.
Published: (2023-04-01)

Early Thrombotic Microangiopathy After ABO-Incompatible Living Donor Kidney Transplantation
by: Dominique Bertrand, et al.
Published: (2025-03-01)

Clinical characteristics and genetic profile of complement system in renal thrombotic microangiopathy in patients with severe forms of arterial hypertension
by: Mariam I. Akaeva, et al.
Published: (2024-01-01)

Thrombotic microangiopathy after kidney transplantion
by: Mohammad Sami Tahseen, et al.
Published: (2023-12-01)

THROMBOTIC MICROANGIOPATHY IN THE PATHOGENESIS OF OBSTETRIC COMPLICATIONS
by: S. V. Akinshina, et al.
Published: (2016-06-01)

COVID-19 and thrombotic microangiopathy
by: E. V. Sluhanchuk, et al.
Published: (2022-01-01)

Disseminated cerebral thrombotic microangiopathy in a patient with adult's Still disease
by: Renan B. Domingues, et al.
Published: (2003-06-01)

Diagnostic Value of Biological Parameters in Biopsy-Confirmed Thrombotic Microangiopathy–MATRIX Consortium Group
by: Jean-Michel Halimi, et al.
Published: (2025-06-01)

Time course of organ and hematological response to complement blockage in transplant-associated thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation
by: Tatiana A. Rudakova, et al.
Published: (2025-03-01)

“Eculizumab First” in the Management of Posttransplant Thrombotic Microangiopathy
by: Federica Maritati, et al.
Published: (2024-04-01)

Clinical case of thrombotic microangiopathy in obstetric practice
by: M. N. Mochalova, et al.
Published: (2017-06-01)

Fatal thrombotic microangiopathy in an infant with COVID-19: a case report
by: Özlem Sarıtaş Nakip, et al.
Published: (2023-08-01)

OCCURRENCE OF THROMBOTIC MICROANGIOPATHY IN A PATIENT WITH GRANULOMATOSIS WITH POLYANGIITIS AFTER REMISSION INDUCTION THERAPY: A RARE PRESENTATION
by: Ege Sinan Torun, et al.
Published: (2024-01-01)

Basiliximab for early perioperative transplant-associated thrombotic microangiopathy after lung transplantation: a case report
by: Naohiro Ijiri, et al.
Published: (2022-09-01)

Thrombotic Microangiopathy After Lung Transplantation: A Retrospective Observational Multicenter Cohort Study
by: Pierre Gazengel, MD, et al.
Published: (2025-08-01)

Renal thrombotic microangiopathy associated with lupus nephritis: Two case reports and review of the literature
by: Jean Carlos Alves de Lima Souza, et al.
Published: (2025-06-01)

Systematic Review of Individual Patient Data COVID-19 Infection and Vaccination–Associated Thrombotic Microangiopathy
by: Pujan Moradiya, et al.
Published: (2024-11-01)

Atypical Hemolytic Uremic Syndrome in a Postoperative Patient: Diagnostic Challenges and Therapeutic Strategies
by: Ayda Fathollah Pour, et al.
Published: (2025-06-01)

Outcome of proliferative lupus nephritis with thrombotic microangiopathy; An ambispective observational single-center study
by: Ahmed Fayed, et al.
Published: (2025-05-01)

Thrombotic Microangiopathy in the Postpartum Period (Literature Review, Clinical Case Report)
by: L. Markin, et al.
Published: (2024-09-01)

Linking preclinical models to clinical realities: VEGF/VEGFR inhibitors and thrombotic microangiopathy in cancer therapy
by: Aimin Jiang, et al.
Published: (2025-06-01)

HLA-DR-DQ associations, combined with PLASMIC score, are reliable predictors of acquired thrombotic thrombocytopenic purpura (aTTP) and aid in differentiating aTTP from other thrombotic microangiopathies
by: Soumya Pandey, et al.
Published: (2024-11-01)

Delayed Onset of Thrombotic Microangiopathy (TMA) upon Prolonged Carfilzomib Therapy in Multiple Myeloma: A Case Report and Comprehensive Review
by: Andrea Ceglédi, et al.
Published: (2024-12-01)

Thrombotic Microangiopathy Complicating Cyclosporine in Renal Transplant Patients
by: Safa Al-Mukhtar
Published: (2023-04-01)

Systematic Review of the Outcomes and Prognostic Factors of Patients With Systemic Lupus Erythematosus-Associated Thrombotic Microangiopathy
by: Yixuan Gai, et al.
Published: (2025-07-01)

Thrombotic Thrombocytopenic Purpura as a Rare Etiopathogenetic Cause of Cerebral Infarction and Extracerebral Thrombosis
by: А. R. Аvidzba, et al.
Published: (2021-08-01)

Acute Kidney Injury Secondary to Pegylated Liposomal Doxorubicin-Associated Renal-limited Thrombotic Microangiopathy
by: Tarek S. Karam, et al.
Published: (2025-05-01)

Cholecystectomy-induced thrombotic microangiopathy (TMA) in a postpartum patient successfully treated with eculizumab: a case report
by: Ashley Meyer, et al.
Published: (2024-12-01)

COVID-19 Microangiopathy: Insights into plasma exchange as a therapeutic strategy
by: Yigit Baykara, et al.
Published: (2025-10-01)

Pancreatic Cancer Presenting with Thrombotic Thrombocytopenic Purpura: A Case Report and Review of Literature
by: Yeh-Chin Wang, et al.
Published: (2025-04-01)

Role of therapeutic plasma exchange in dengue-related microangiopathy
by: Aarushi Sahni, et al.
Published: (2025-07-01)